Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 oct. 2016 07h00 HE | Source: Inspyr Therapeutics

Inspyr Broadens Intellectual Property Portfolio with New Patent Issued on Methods for Producing Cancer Compounds

WESTLAKE VILLAGE, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...
13 oct. 2016 07h00 HE | Source: Inspyr Therapeutics

Inspyr Therapeutics Appoints Richard Buller, M.D., Ph.D. to Board of Directors

WESTLAKE VILLAGE, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...
12 oct. 2016 07h00 HE | Source: Inspyr Therapeutics

Inspyr Therapeutics Appoints Claire Thom, Pharm.D. to Board of Directors

WESTLAKE VILLAGE, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...
11 oct. 2016 07h00 HE | Source: Inspyr Therapeutics

Inspyr Therapeutics Strengthens Clinical Development Capabilities with Appointment of Michael Elliott as Vice President of Clinical Operations

WESTLAKE VILLAGE, Calif., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced...